EIR Tergus Pharma Sep 2019

Srinivas Chennamaneni FDA, Betsy Galliher FDA$595.00 - Available Now

FDA investigators audited the Tergus Pharma - Durham, NC, United States facility and issued inspectional observation (via FDA 483) on 27 Sep 2019.

Product details

  • Category:
  • Inspection end: 27 Sep 2019
  • Location: Durham, United States
  • FEI: 3004570125
Add To Cart